Exelixis Inc Inventory Write-down
Exelixis Inc (EXEL) reported Inventory Write-down of $2.30 million for the 6-month period ending 2021-07-02, per its 10-Q filed 2021-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2021-08-05
- Exelixis Inc inventory write-down for the quarter ending 2021-07-02 was $200.00K, a 81.82% decline year-over-year.
- Exelixis Inc inventory write-down for the quarter ending 2021-04-02 was $2.10M, a 950.00% increase year-over-year.
- Exelixis Inc inventory write-down for the quarter ending 2021-01-01 was $500.00K, a 44.44% decline year-over-year.
- Exelixis Inc inventory write-down for the quarter ending 2020-10-02 was $900.00K.
- Exelixis Inc inventory write-down for fiscal 2021 was $2.70M, a 107.69% increase from fiscal 2020.
- Exelixis Inc inventory write-down for fiscal 2020 was $1.30M, a 18.18% increase from fiscal 2018.
- Exelixis Inc inventory write-down for fiscal 2018 was $1.10M, a 8.33% decline from fiscal 2017.
- Exelixis Inc inventory write-down for fiscal 2017 was $1.20M, a 140.00% increase from fiscal 2016.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 9 month as first filed | Inventory Write-down 12 month |
|---|---|---|---|---|---|
| 2021-07-02 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $2.30M 10-Q · filed 2021-08-05 | $2.80M derived: sum of 3 quarters · filed 2021-08-05 | $3.70M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2021-04-02 | $2.10M 10-Q · filed 2021-05-06 | $2.60M derived: sum of 2 quarters · filed 2021-05-06 | $3.50M derived: sum of 3 quarters · filed 2021-05-06 | $4.60M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2021-01-01 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $1.40M derived: sum of 2 quarters · filed 2021-02-11 | $2.50M derived: sum of 3 quarters · filed 2021-08-05 | $2.70M 10-K · filed 2021-02-11 | |
| 2020-10-02 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.00M derived: sum of 2 quarters · filed 2021-08-05 | $2.20M 10-Q · filed 2020-11-05 | $3.10M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-07-03 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.30M 10-Q · filed 2021-08-05 | $2.20M derived: sum of 3 quarters · filed 2021-08-05 | $2.20M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-04-03 | $200.00K 10-Q · filed 2021-05-06 | $1.10M derived: sum of 2 quarters · filed 2021-05-06 | $1.10M derived: sum of 3 quarters · filed 2021-05-06 | $1.30M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2020-01-03 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $900.00K derived: sum of 2 quarters · filed 2021-02-11 | $1.10M derived: sum of 3 quarters · filed 2021-02-11 | $1.30M 10-K · filed 2021-02-11 | |
| 2019-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $200.00K derived: sum of 2 quarters · filed 2020-11-05 | $400.00K 10-Q · filed 2020-11-05 | $700.00K derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-28 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $400.00K 10-Q · filed 2020-08-06 | $700.00K derived: sum of 3 quarters · filed 2020-08-06 | $1.00M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-29 | $200.00K 10-Q · filed 2019-05-01 | $500.00K derived: sum of 2 quarters · filed 2020-02-25 | $800.00K derived: sum of 3 quarters · filed 2020-02-25 | $1.30M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-12-28 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $600.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.10M derived: sum of 3 quarters · filed 2020-02-25 | $1.10M 10-K · filed 2021-02-11 | |
| 2018-09-28 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $800.00K derived: sum of 2 quarters · filed 2019-10-30 | $800.00K 10-Q · filed 2019-10-30 | $800.00K derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-29 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $500.00K 10-Q · filed 2019-07-31 | $500.00K derived: sum of 3 quarters · filed 2020-02-25 | $1.20M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-30 | $0.00 10-Q · filed 2019-05-01 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $700.00K derived: sum of 3 quarters · filed 2020-02-25 | ||
| 2017-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $700.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.20M 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $1.20M 10-Q · filed 2017-11-01 | |||
| 2017-09-29 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $700.00K derived: sum of 2 quarters · filed 2018-11-01 | $1.20M 10-Q · filed 2018-11-01 | $1.30M derived: sum of 4 quarters · filed 2018-11-01 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $500.00K 10-Q · filed 2017-08-02 | $600.00K derived: sum of 3 quarters · filed 2018-05-02 | $1.00M derived: sum of 4 quarters · filed 2018-05-02 | |
| 2017-03-31 | $500.00K 10-Q · filed 2017-05-01 | $600.00K derived: sum of 2 quarters · filed 2018-05-02 | $1.00M derived: sum of 3 quarters · filed 2018-05-02 | $1.00M derived: sum of 4 quarters · filed 2018-05-02 | |
| 2016-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $500.00K derived: sum of 2 quarters · filed 2017-02-27 | $500.00K derived: sum of 3 quarters · filed 2017-08-02 | $500.00K 10-K · filed 2017-02-27 | |
| 2016-12-30 | $500.00K 10-K · filed 2019-02-22 | ||||
| 2016-09-30 | $400.00K 10-Q · filed 2016-11-03 | $400.00K derived: sum of 2 quarters · filed 2017-08-02 | $400.00K 10-Q · filed 2017-11-01 | $700.00K derived: sum of 4 quarters · filed 2017-08-02 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $0.00 10-Q · filed 2017-08-02 | $300.00K derived: sum of 3 quarters · filed 2017-08-02 | $1.40M derived: sum of 4 quarters · filed 2017-08-02 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-04 | $300.00K derived: sum of 2 quarters · filed 2017-02-27 | $1.40M derived: sum of 3 quarters · filed 2017-02-27 | ||
| 2016-01-01 | $1.20M 10-K · filed 2018-02-26 | ||||
| 2015-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.40M derived: sum of 2 quarters · filed 2017-02-27 | $1.20M 10-K · filed 2017-02-27 | ||
| 2015-09-30 | $1.10M 10-Q · filed 2016-11-03 | $900.00K 10-Q · filed 2016-11-03 | $1.10M 10-Q · filed 2015-11-10 | ||
| 2015-06-30 | $200.00K 10-Q · filed 2016-08-03 | ||||
| 2014-12-31 | $200.00K 10-K · filed 2016-02-29 | ||||
| 2013-12-31 | $39.00K 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |